Bone anabolic effect of ixazomib - a third generation proteasome inhibitor – in multiple myeloma patients

Marta Diaz-Delcastillo, Gundesen MT, Christian Andersen, Anne Nielsen, Hanne E. H. Møller, Pernille Vinholt, Jon Thor Asmussen, Ida Bruun Kristensen, Charlotte Guldborg Nyvold, Niels Abildgaard, Thomas Andersen, Thomas Lund

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberP-036
JournalClinical Lymphoma Myeloma and Leukemia
Issue numberSuppl.
Pages (from-to)55
Number of pages1
Publication statusPublished - 2022
Event19th International Myeloma Society Annual Meeting - Los Angeles, United States
Duration: 25. Aug 202227. Aug 2022


Conference19th International Myeloma Society Annual Meeting
Country/TerritoryUnited States
CityLos Angeles

Cite this